Semaglutide Before and After: What Real Results Actually Look Like
In the STEP 1 trial, adults on semaglutide 2.4 mg lost an average of about 15% of their body weight by week 68 (versus about 2.4% on placebo). That single number hides a wide spread: roughly 30% of participants lost more than 20%, about two-thirds lost at least 10%, and about 1 in 10 lost less than 5%. Before-and-after results a year in are the norm to expect; dramatic month-one photos usually are not. Here is what the trial data shows honestly, why photos on the internet often mislead, and what results look like if you stop.
What Do Semaglutide Before and After Results Actually Look Like?
The honest answer is a range, not a headline number.
The STEP 1 trial is the largest published study of semaglutide 2.4 mg for weight loss. It followed nearly 2,000 adults for 68 weeks (about 16 months). At the end, average body-weight loss was 14.9% in the semaglutide group and 2.4% in the placebo group, both alongside diet and activity changes.
Averages hide a lot. Here is how participants actually sorted out on the primary weight-loss milestones at week 68:
| Weight lost by week 68 | Share of semaglutide participants | What that looks like on a 220 lb starting weight |
|---|---|---|
| Less than 5% | About 1 in 10 | Less than 11 lb |
| At least 5% | About 86% | 11 lb or more |
| At least 10% | About 2 in 3 | 22 lb or more |
| At least 15% | About half | 33 lb or more |
| More than 20% | About 3 in 10 | 44 lb or more |
Two things worth naming plainly. First, these figures are on the full 2.4 mg weight-management dose (Wegovy), not on lower diabetes-dose semaglutide (Ozempic at 0.5 to 2.0 mg), which produces smaller average weight loss. Second, they are results at 68 weeks, not at 68 days. Most of the loss happens in the first year on the full dose; a big jump in the first month is unusual and usually a sign of water loss or reduced calorie intake, not fat.
How the Timeline Actually Runs
Real before-and-after comparisons should be at least three months apart, ideally more.
Semaglutide is titrated up over 16 weeks, so the strongest weekly weight loss typically comes after week 16, not in the first month. That is by design: the low starting doses are for tolerance, and pushing higher too fast increases nausea.
A useful mental model for before-and-after photos:
- Month 1 (0.25 mg starting dose): appetite change is common, visible weight change is not. Photos this early rarely show much.
- Months 2 to 4 (dose stepping up to 1.0 to 1.7 mg): weight loss becomes more consistent week to week, often 1 to 2 lb per week.
- Month 4 onward (full 2.4 mg maintenance): the biggest visible changes accumulate here, through about month 12 to 16.
- Year 2 (STEP 5 data): loss is largely maintained on the full dose, with small additional loss for some people and a plateau for most.
For a week-by-week breakdown of what happens on the standard titration schedule, see How long does semaglutide take to work. For the dose schedule itself, see Semaglutide dosage and titration schedule.
Why Semaglutide Before-and-After Photos Online Often Mislead
Photos are not evidence, especially on ads and social posts.
Real trial photos of specific participants are not publicly available (privacy rules, informed consent). Almost every dramatic before-and-after image circulating online is one of four things, and only one of them is what it claims to be:
- Stock photography. Two different people, sometimes years apart, presented as one weight-loss story. Common on affiliate landing pages and compounded-provider ads. If the same photo appears on multiple unrelated sites, it is stock.
- Lighting, pose, and clothing tricks. Same person, same day, different posture, different lens, different lighting. This can fake 20 lb of visible difference with zero actual change.
- Cherry-picked responders. A real person’s real result, but from the top 10 to 20% of the distribution. Marketing rarely shows the person who lost 3% or the person who stopped due to side effects.
- Honest documentation, months apart, same conditions. Rare and useful. Same lighting, same time of day, same neutral posture, dates in the frame. This is the only category worth much.
None of this means semaglutide does not work. It means “before and after” is a marketing format, not a data source. The trials are the data source.
What Actually Changes Your Results
Three factors do most of the work. Everything else is smaller.
Reaching and staying on the full dose. The 15% average is on the full 2.4 mg maintenance dose. People who stop stepping up at 1.0 mg (because of insurance limits, side effects, or a provider’s caution) tend to see smaller loss overall. If cost is what is capping the dose, our Wegovy and Zepbound savings card guide and GLP-1 insurance coverage checker cover what actually reduces the out-of-pocket.
Diet and activity alongside the medication. STEP 1 participants also had lifestyle intervention (calorie guidance, activity encouragement, monthly counseling). The 15% figure is not the medication alone; it is the medication plus that support. Semaglutide quiets appetite but does not choose what you eat when you do eat.
Time on treatment. The strongest weekly loss is roughly months 4 to 9. Cutting treatment short at 3 or 4 months usually means only capturing the early portion of the curve. If loss stalls before the full dose, that is often normal titration behavior, not treatment failure. See Semaglutide side effects for what to expect and what usually eases.
Smaller factors that still matter: sleep quality, alcohol intake, resistance training (protects lean mass during weight loss), and consistency of injection timing. None of them are magic, and none of them override dose and duration.
What Happens to Results If You Stop Semaglutide?
Most of the loss comes back within a year, on average.
The STEP 1 trial extension followed participants for a year after they stopped semaglutide. The average result was regain of about two-thirds of the weight lost within 12 months, alongside partial reversal of the cardiometabolic improvements (blood pressure, waist circumference, HbA1c). This mirrors what is seen with obesity treatments generally: obesity behaves as a chronic condition, and stopping treatment usually shifts weight back toward the starting point.
That is not a reason to stay on semaglutide forever no matter what; it is a reason to think about stopping the same way you would think about stopping a blood-pressure medication. A prescribing provider is the right person to plan a taper, a switch, or a maintenance dose.
If you are weighing options across brands and delivery methods before starting, see What is semaglutide and how does it work for the pharmacology and Is Wegovy the same as semaglutide for the brand and compounded comparison.